Fig 1: Expression of POSTN in inverted papillomas patients, as indicated by (A) the mRNA levels, (B) serum levels, and (C) protein levels of POSTN. Data are compared using unpaired Student’s t-test and are presented as means ± SD. p-values are indicated with ns, non-significant.
Fig 2: Expression of POSTN in cysts patients, as indicated by (A) the mRNA levels, (B) serum levels, and (C) protein levels of POSTN. Data are compared using unpaired Student’s t-test and are presented as means ± SD. p-values are indicated with * p < 0.05; ns, non-significant.
Fig 3: Expression of POSTN in choanopolyps patients, as indicated by (A) the mRNA levels, (B) serum levels, and (C) protein levels of POSTN. Data are compared using unpaired Student’s t-test and are presented as means ± SD. p-values are indicated with * p < 0.05; ns, non-significant.
Fig 4: Expression of POSTN in mucoceles patients, as indicated by (A) the mRNA levels, (B) serum levels, and (C) protein levels of POSTN. Data are compared using unpaired Student’s t-test and are presented as means ± SD. p-values are indicated with * p < 0.05; ** p < 0.01.
Supplier Page from OriGene Technologies for Human Periostin/OSF2 ELISA Kit